LYVA Labs Invests in Female-Led AI Health Startup Spotlight Pathology
LYVA Labs, a Liverpool-based company, is making significant investments in under-served founders and CEOs, particularly focusing on female-led businesses. The company recently backed Spotlight Pathology with £125k from its Health and Life Sciences pre-seed fund. This funding will allow Spotlight Pathology to accelerate product development and commercialization of AI tools designed to aid pathologists in diagnosing blood cancer.
Spotlight Pathology, which was spun out of the University of Manchester by Dr.
Martin Fergie and Prof. Richard Byers, recently received investment from LYVA Labs after relocating to Daresbury. The company has already secured a significant Innovate UK grant and aims to streamline the diagnosis process for blood cancer. Dr. Sam Perona, former CEO of Perfectus Biomed, has joined Spotlight Pathology as CEO and is excited about the investment from LYVA Labs, which will enable the company to grow the team and accelerate their 'Go to Market' plan.
LYVA Labs, with funding from Liverpool City Region's Combined Authority, aims to turn innovative ideas into high-growth businesses and quality jobs, with a focus on boosting AI tech companies in the North West. The company is dedicated to supporting ambitious female entrepreneurs and has set up initiatives like the Female Founder Regional HIGH Growth Board to increase the flow of capital to regional female founders. With a vision for the region to be internationally recognized as an open innovation ecosystem, LYVA Labs is making early-stage investments in key growth technologies to drive economic growth in Liverpool City Region.
They've invested in Spotlight Pathology
Get to know these AI investors
Click here for a full list of 6,908+ startup investors in the UK